Ferritin aggregation cell engager for CAR T avidity engineering against refractory leukemias
Fahui Li, Yuxing Hu, Yan Wang, Xiao Zhang et autres
cn, us, au (code pays fourni par la source)
2 citations
Cell
Xiaobei Hu
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
36Publications signalées
677Citations signalées
1Affiliations récentes
Les institutions déclarées
Les domaines associés
Protein Degradation and InhibitorsUbiquitin and proteasome pathwaysMultiple Myeloma Research and TreatmentsHistone Deacetylase Inhibitors ResearchAcute Myeloid Leukemia Research
Les publications récentes
[Progress and challenges of poly (L-lactic acid) membrane in preventing tendon adhesion].
J. Zhang, Xiaobei Hu, Jiayan Shen, Shen Liu
cn (code pays fourni par la source)
0 citations
PubMed
Prognostic impact of total (Ipsilateral) retroperitoneal lipectomy vs. complete resection in retroperitoneal liposarcoma: A retrospective cohort study with nomogram
Qisheng Hao, Qingze Li, Hongliang Liu, Kang Fu et autres
cn (code pays fourni par la source)
1 citation
European Journal of Surgical Oncology
Harnessing the Magic Methyl Effect: Discovery of CLPP-2068 as a Novel Hs ClpP Activator for the Treatment of Diffuse Large B-Cell Lymphoma
Mingyang Sun, Beijing Chen, Dan Teng, Hongshen Zhao et autres
cn (code pays fourni par la source)
14 citations
Journal of Medicinal Chemistry
Discovery of CLPP-1071 as an Exceptionally Potent and Orally Efficacious Human ClpP Activator with Strong In Vivo Antitumor Activity
Beijing Chen, Mingyang Sun, Chun Zhang, Qi Huang et autres
cn (code pays fourni par la source)
15 citations
Journal of Medicinal Chemistry
Discovery of Novel 2-Aminopyridine-Based and 2-Aminopyrimidine-Based Derivatives as Potent CDK/HDAC Dual Inhibitors for the Treatment of Refractory Solid Tumors and Hematological Malignancies
Abdusaid Saidahmatov, Jianan Li, Shihao Xu, Xiaobei Hu et autres
cn (code pays fourni par la source)
25 citations
Journal of Medicinal Chemistry
Discovery of Preclinical Candidate AD1058 as a Highly Potent, Selective, and Brain-Penetrant ATR Inhibitor for the Treatment of Advanced Malignancies
Zhi Liu, Kailong Jiang, Yan Liu, J. Li et autres
cn (code pays fourni par la source)
14 citations
Journal of Medicinal Chemistry
Discovery of JN122, a Spiroindoline-Containing Molecule that Inhibits MDM2/p53 Protein–Protein Interaction and Exerts Robust In Vivo Antitumor Efficacy
Jing Cheng, Ziqin Yan, Kailong Jiang, Chen Liu et autres
cn (code pays fourni par la source)
17 citations
Journal of Medicinal Chemistry
Discovery of 2-Aminopyrimidine Derivatives as Potent Dual FLT3/CHK1 Inhibitors with Significantly Reduced hERG Inhibitory Activities
Xuemei Li, Peipei Wang, Chang Wang, Tingting Jin et autres
cn (code pays fourni par la source)
12 citations
Journal of Medicinal Chemistry
Targeting C/EBPα overcomes primary resistance and improves the efficacy of FLT3 inhibitors in acute myeloid leukaemia
Hanlin Wang, Guanghao Luo, Xiaobei Hu, Gaoya Xu et autres
cn (code pays fourni par la source)
5 citations
Nature Communications
Dual inhibition of CHK1/FLT3 enhances cytotoxicity and overcomes adaptive and acquired resistance in FLT3-ITD acute myeloid leukemia
Kailong Jiang, Xuemei Li, Chang Wang, Xiaobei Hu et autres
cn (code pays fourni par la source)
21 citations
Leukemia
Design, synthesis, and biological evaluation of Wee1 kinase degraders
Shulei Zhu, Jieyu Liu, Donghuai Xiao, Peipei Wang et autres
cn (code pays fourni par la source)
13 citations
European Journal of Medicinal Chemistry
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.